All Categories
Get it between 2024-12-10 to 2024-12-17. Additional 3 business days for provincial shipping.
FLEXIBLE DESIGN: A thin, flexible, highly adhesive patch that contours to your body
MAXIMUM OTC STRENGTH: Our flex patch is unscented and contains maximum Over The Counter strength Lidocaine 4%, available without a prescription
LASTING RELIEF: Apply for up to 8 hours, (no more than 3-4 applications a day), with the powerful formula of Salonpas FLEX patches
STRONG ADHESION, EASY APPLICATION: Convenient patches adhere securely so that you can move, bend, twist and FLEX
TRUSTED BRAND: Salonpas is a trusted name in pain relief and is the #1 Doctor recommended OTC pain relief patch brand*, #1 Pharmacist recommended OTC pain relief patch brand** and #1 Worldwide brand of OTC pain relief patches
Salonpas Lidocaine 4% FLEX Pain Relieving Patch is from the World’s #1 brand of pain patches. Thin, lightweight, flexible, and highly adhesive, the Salonpas FLEX Pain Relieving Patch provides flexible pain relief that moves with you. The Salonpas FLEX fabric stretches in all directions to move with the body, and the strong adhesion makes this a great pain patch for body parts that move, bend, twist, and FLEX. The Salonpas Pain Relieving FLEX Patch has maximum strength Lidocaine available without a prescription (4% Lidocaine). Try Salonpas first – topical pain relievers, like Salonpas FLEX Pain Relieving Patch, provide temporary relief of minor aches and pains, are non-addictive, and are gentle on the body. Salonpas FLEX pain patches are approximately 3.94 inches x 2.75 inches to fit easily on difficult areas of the body. They have rounded corners that help resist peeling so they stay in place. A great pain relieving patch for feet, elbows, knees, shoulders, back, and other parts of your body – Salonpas, It’s Good Medicine. *(Topical Analgesic Patch Data, IQVIA Pro Voice Survey 2022) **(Topical Analgesic Patch Data, IQVIA Pro Voice Survey 2022) †(Euromonitor International Limited; in terms of retail sales value in 2022, based on the custom research conducted in March April 2023 in the countries that account for more than 70% share of the global topical analgesics/anesthetic market in 2022.)